Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats

Abstract In diabetes, retinal dysfunctions exist prior to clinically detectable vasculopathy, however the pathology behind these functional deficits is still not fully established. Previously, our group published a detailed study on the retinal histopathology of type 1 diabetic (T1D) rat model, wher...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Klaudia Szabó, Anna Énzsöly, Bulcsú Dékány, Arnold Szabó, Rozina I. Hajdú, Tamás Radovits, Csaba Mátyás, Attila Oláh, Lenke K. Laurik, Gábor M. Somfai, Béla Merkely, Ágoston Szél, Ákos Lukáts
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/57d0d283bf724bdb8426c37685ee16e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:57d0d283bf724bdb8426c37685ee16e6
record_format dspace
spelling oai:doaj.org-article:57d0d283bf724bdb8426c37685ee16e62021-12-02T12:30:19ZHistological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats10.1038/s41598-017-09068-62045-2322https://doaj.org/article/57d0d283bf724bdb8426c37685ee16e62017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09068-6https://doaj.org/toc/2045-2322Abstract In diabetes, retinal dysfunctions exist prior to clinically detectable vasculopathy, however the pathology behind these functional deficits is still not fully established. Previously, our group published a detailed study on the retinal histopathology of type 1 diabetic (T1D) rat model, where specific alterations were detected. Although the majority of human diabetic patients have type 2 diabetes (T2D), similar studies on T2D models are practically absent. To fill this gap, we examined Zucker Diabetic Fatty (ZDF) rats - a model for T2D - by immunohistochemistry at the age of 32 weeks. Glial reactivity was observed in all diabetic specimens, accompanied by an increase in the number of microglia cells. Prominent outer segment degeneration was detectable with changes in cone opsin expression pattern, without a decrease in the number of labelled elements. The immunoreactivity of AII amacrine cells was markedly decreased and changes were detectable in the number and staining of some other amacrine cell subtypes, while most other cells examined did not show any major alterations. Overall, the retinal histology of ZDF rats shows a surprising similarity to T1D rats indicating that despite the different evolution of the disease, the neuroretinal cells affected are the same in both subtypes of diabetes.Klaudia SzabóAnna ÉnzsölyBulcsú DékányArnold SzabóRozina I. HajdúTamás RadovitsCsaba MátyásAttila OláhLenke K. LaurikGábor M. SomfaiBéla MerkelyÁgoston SzélÁkos LukátsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-17 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Klaudia Szabó
Anna Énzsöly
Bulcsú Dékány
Arnold Szabó
Rozina I. Hajdú
Tamás Radovits
Csaba Mátyás
Attila Oláh
Lenke K. Laurik
Gábor M. Somfai
Béla Merkely
Ágoston Szél
Ákos Lukáts
Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats
description Abstract In diabetes, retinal dysfunctions exist prior to clinically detectable vasculopathy, however the pathology behind these functional deficits is still not fully established. Previously, our group published a detailed study on the retinal histopathology of type 1 diabetic (T1D) rat model, where specific alterations were detected. Although the majority of human diabetic patients have type 2 diabetes (T2D), similar studies on T2D models are practically absent. To fill this gap, we examined Zucker Diabetic Fatty (ZDF) rats - a model for T2D - by immunohistochemistry at the age of 32 weeks. Glial reactivity was observed in all diabetic specimens, accompanied by an increase in the number of microglia cells. Prominent outer segment degeneration was detectable with changes in cone opsin expression pattern, without a decrease in the number of labelled elements. The immunoreactivity of AII amacrine cells was markedly decreased and changes were detectable in the number and staining of some other amacrine cell subtypes, while most other cells examined did not show any major alterations. Overall, the retinal histology of ZDF rats shows a surprising similarity to T1D rats indicating that despite the different evolution of the disease, the neuroretinal cells affected are the same in both subtypes of diabetes.
format article
author Klaudia Szabó
Anna Énzsöly
Bulcsú Dékány
Arnold Szabó
Rozina I. Hajdú
Tamás Radovits
Csaba Mátyás
Attila Oláh
Lenke K. Laurik
Gábor M. Somfai
Béla Merkely
Ágoston Szél
Ákos Lukáts
author_facet Klaudia Szabó
Anna Énzsöly
Bulcsú Dékány
Arnold Szabó
Rozina I. Hajdú
Tamás Radovits
Csaba Mátyás
Attila Oláh
Lenke K. Laurik
Gábor M. Somfai
Béla Merkely
Ágoston Szél
Ákos Lukáts
author_sort Klaudia Szabó
title Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats
title_short Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats
title_full Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats
title_fullStr Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats
title_full_unstemmed Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats
title_sort histological evaluation of diabetic neurodegeneration in the retina of zucker diabetic fatty (zdf) rats
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/57d0d283bf724bdb8426c37685ee16e6
work_keys_str_mv AT klaudiaszabo histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT annaenzsoly histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT bulcsudekany histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT arnoldszabo histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT rozinaihajdu histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT tamasradovits histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT csabamatyas histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT attilaolah histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT lenkeklaurik histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT gabormsomfai histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT belamerkely histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT agostonszel histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
AT akoslukats histologicalevaluationofdiabeticneurodegenerationintheretinaofzuckerdiabeticfattyzdfrats
_version_ 1718394398875582464